Imran Talat

Imran Talat is listed in filings as Chief Executive Officer at Rani Therapeutics Holdings, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including purchase activity. Recent filings connect the profile to Rani Therapeutics Holdings, Inc. (RANI). The current snapshot covers public activity from Dec 10, 2024 to Jun 5, 2026. Reported amounts are shown as $20.0K to $3.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.